• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康风险行为对美国慢性丙型肝炎成年患者超额死亡率的影响:一项基于人群的队列研究。

The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study.

机构信息

School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, United Kingdom.

Health Protection Scotland, Glasgow Caledonian University, Glasgow, United Kingdom.

出版信息

Hepatology. 2018 Jan;67(1):97-107. doi: 10.1002/hep.29419. Epub 2017 Nov 16.

DOI:10.1002/hep.29419
PMID:28777874
Abstract

UNLABELLED

In resource-rich countries, chronic hepatitis C (CHC) infection is associated with a sizeable excess mortality risk. The extent to which this is due to (1) the biological sequelae of CHC infection versus (2) a high concomitant burden of health risk behaviors (HRBs) is unclear. We used data from the 1999-2010 U.S. National Health and Nutritional Examination Surveys (NHANES), which include detailed information on HRBs and CHC infection status. We calculated the prevalence of the five major HRBs-alcohol use; cigarette smoking, physical inactivity, unhealthy diet, and illicit drug use-according to CHC after adjusting for sociodemographic differences. Mortality status after survey interview was ascertained by linkage to the U.S. National Death Index. To assess the contribution of HRBs to the excess mortality risk, we determined the all-cause mortality rate ratio (MRR) for individuals with CHC relative to individuals without, and then calculated the attenuation in this MRR following adjustment for HRBs. This analysis included 27,468 adult participants of NHANES of which 363 tested positive for CHC. All HRBs were markedly more prevalent among individuals with CHC versus individuals without. CHC was associated with a 2.4-fold higher mortality rate after adjustment for sociodemographic factors (MRR, 2.36; 95% CI, 1.60-3.49). Subsequent adjustment for all five HRBs attenuated this ratio by 50.7% to MRR 1.67 (95% CI, 1.14-2.44). Higher levels of attenuation (69.1%) were observed among individuals aged 45-70 years, who form the target demographic for U.S. birth cohort screening.

CONCLUSION

At least half the excess mortality risk for individuals with CHC in the United States may be attributed to HRBs rather than CHC. The remedial response to hepatitis C must not neglect action on HRBs if it is to fully resolve the high mortality problem in this population. (Hepatology 2018;67:97-107).

摘要

目的

在资源丰富的国家,慢性丙型肝炎(CHC)感染与相当大的超额死亡风险相关。但这种情况是由于(1)CHC 感染的生物学后果,还是(2)同时存在大量健康风险行为(HRB)负担,尚不清楚。我们使用了来自 1999 年至 2010 年美国国家健康和营养检查调查(NHANES)的数据,这些数据包括关于 HRB 和 CHC 感染状况的详细信息。我们根据 CHC 调整了社会人口统计学差异后,计算了五种主要 HRB-饮酒、吸烟、身体活动不足、不健康饮食和非法药物使用的流行率。通过与美国国家死亡指数的链接,确定了调查访谈后的死亡状况。为了评估 HRB 对超额死亡风险的贡献,我们确定了 CHC 个体相对于无 CHC 个体的全因死亡率比(MRR),然后计算了在调整 HRB 后,该 MRR 的衰减程度。这项分析包括了 27468 名 NHANES 的成年参与者,其中 363 名测试呈 CHC 阳性。与无 CHC 个体相比,所有 HRB 在 CHC 个体中明显更为普遍。在调整社会人口统计学因素后,CHC 与死亡率增加 2.4 倍相关(MRR,2.36;95%CI,1.60-3.49)。随后调整所有五个 HRB 将该比值降低 50.7%,降至 MRR 1.67(95%CI,1.14-2.44)。在年龄为 45-70 岁的个体中观察到更高水平的衰减(69.1%),他们是美国出生队列筛查的目标人群。

结论

在美国,CHC 个体的超额死亡风险的至少一半可能归因于 HRB,而不是 CHC。如果要完全解决该人群的高死亡率问题,那么对丙型肝炎的治疗反应绝不能忽视对 HRB 的干预。(Hepatology 2018;67:97-107)。

相似文献

1
The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study.健康风险行为对美国慢性丙型肝炎成年患者超额死亡率的影响:一项基于人群的队列研究。
Hepatology. 2018 Jan;67(1):97-107. doi: 10.1002/hep.29419. Epub 2017 Nov 16.
2
The effects of health risk behaviors to excess mortality in the population with depression: A cohort study based on NHANES data.健康风险行为对抑郁症人群中过度死亡率的影响:基于 NHANES 数据的队列研究。
J Affect Disord. 2024 Jul 1;356:233-238. doi: 10.1016/j.jad.2024.04.038. Epub 2024 Apr 10.
3
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.美国疾病控制与预防中心国家健康报告:2005 - 2013年美国发病和死亡的主要原因以及相关行为风险和保护因素
MMWR Suppl. 2014 Oct 31;63(4):3-27.
4
Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.丹麦和苏格兰慢性丙型肝炎病毒感染所致的肝死亡率——以自发缓解者作为基准对照。
Hepatology. 2016 May;63(5):1506-16. doi: 10.1002/hep.28458. Epub 2016 Mar 19.
5
Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population.美国人口中丙型肝炎、糖尿病、肥胖症和慢性肾脏病流行的交汇。
Clin Gastroenterol Hepatol. 2017 Dec;15(12):1957-1964.e7. doi: 10.1016/j.cgh.2017.04.046. Epub 2017 Jun 1.
6
Association Between Comorbid Anxiety and Depression and Health Risk Behaviors Among Chinese Adolescents: Cross-Sectional Questionnaire Study.焦虑和抑郁共病与中国青少年健康风险行为的关系:横断面问卷调查研究。
JMIR Public Health Surveill. 2023 Jul 5;9:e46289. doi: 10.2196/46289.
7
Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt.与丙型肝炎病毒感染相关的超额死亡率:埃及农村的一项基于社区的队列研究。
J Hepatol. 2016 Jun;64(6):1240-6. doi: 10.1016/j.jhep.2016.02.033. Epub 2016 Feb 26.
8
Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study.糖尿病和乙型肝炎病毒合并感染对慢性丙型肝炎患者的影响:一项全港范围的队列研究。
J Gastroenterol Hepatol. 2018 Apr;33(4):934-941. doi: 10.1111/jgh.14003. Epub 2018 Jan 26.
9
Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.慢性丙型肝炎患者肝脏相关死亡率的危险因素:一项死亡病例-存活对照研究。
World J Gastroenterol. 2014 May 14;20(18):5519-26. doi: 10.3748/wjg.v20.i18.5519.
10
The Epidemiology of Cirrhosis in the United States: A Population-based Study.美国肝硬化的流行病学:一项基于人群的研究。
J Clin Gastroenterol. 2015 Sep;49(8):690-6. doi: 10.1097/MCG.0000000000000208.

引用本文的文献

1
Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment.一项回顾性病例发现和重新参与活动的结果,旨在提高以前诊断为丙型肝炎病毒的人的直接抗病毒治疗的接受率。
BMC Public Health. 2024 Sep 6;24(1):2427. doi: 10.1186/s12889-024-19919-3.
2
Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making.预测肝细胞癌发生的预后模型中的竞争风险偏倚:对临床决策的影响。
Gastro Hep Adv. 2022 Feb 3;1(2):129-136. doi: 10.1016/j.gastha.2021.11.008. eCollection 2022.
3
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.
在患有晚期纤维化/肝硬化的HIV/HCV合并感染患者中,使用直接作用抗病毒药物清除HCV后的临床结局和预后因素。
Hepatology. 2025 Jan 1;81(1):238-253. doi: 10.1097/HEP.0000000000000838. Epub 2024 Mar 7.
4
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.在无干扰素抗病毒药物时代成功治疗丙型肝炎患者的死亡率:基于人群的队列研究。
BMJ. 2023 Aug 2;382:e074001. doi: 10.1136/bmj-2022-074001.
5
Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease.美国慢性肾脏病成年患者坚持推荐体力活动的趋势及其与死亡率和疾病进展的关系。
Am J Nephrol. 2022;53(8-9):591-602. doi: 10.1159/000526956. Epub 2022 Nov 7.
6
Contextualizing Canada's hepatitis C virus epidemic.解读加拿大丙型肝炎病毒疫情
Can Liver J. 2018 Dec 25;1(4):218-230. doi: 10.3138/canlivj.2018-0011. eCollection 2018 Fall.
7
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis.直接作用抗病毒治疗的接受情况和持续病毒学应答结果不受饮酒影响:一项加拿大大学健康网络分析。
Can Liver J. 2021 Aug 9;4(3):283-291. doi: 10.3138/canlivj-2021-0003. eCollection 2021 Summer.
8
Trends and Disparities in Treatment Utilization for Early-Stage Hepatocellular Carcinoma in the Veteran Population.退伍军人人群中早期肝细胞癌治疗利用的趋势和差异。
Ann Surg Oncol. 2022 Sep;29(9):5488-5497. doi: 10.1245/s10434-022-11897-3. Epub 2022 May 22.
9
Relationship between Morbidity and Health Behavior in Chronic Diseases.慢性病发病率与健康行为之间的关系。
J Clin Med. 2020 Jan 2;9(1):121. doi: 10.3390/jcm9010121.
10
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study.在丙型肝炎病毒直接作用抗病毒治疗期间和之后,使用直接作用抗病毒药物治疗的近期注射吸毒或接受阿片类激动剂治疗者的药物和酒精使用模式及注射设备共用情况:一项国际研究。
Clin Infect Dis. 2020 May 23;70(11):2369-2376. doi: 10.1093/cid/ciz633.